CLINICAL_TRIALS
trial_result
· 2015-11-03
Clinical Trial Update: E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures [Phase 2]
Summary
A Phase 2 trial evaluated E2007 (perampanel) as adjunctive therapy for patients with refractory partial seizures. The study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED